Lataa...
New Schizophrenia Treatments Address Unmet Clinical Needs
We present several novel drugs in development for enhancing cognition, treating negative symptoms, and providing improved options for treatment-resistant patients. Drug makers aim to enhance safety profiles and increase patient compliance to therapy.
Tallennettuna:
| Julkaisussa: | P T |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MediMedia USA, Inc.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5265239/ https://ncbi.nlm.nih.gov/pubmed/28163559 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|